Same Questions, Different Budgets

Fortune 100 healthcare companies have entire strategy departments — analysts, consultants, intelligence teams — answering competitive questions, evaluating market entry, stress-testing decisions.

The questions don't get smaller just because the budget does.

Mid-market companies face the same complexity with a fraction of the resources. Codex Lab closes that gap — the same analytical rigor, scoped to mid-market economics, with intelligence that compounds over time.

Built Different by Design

Intelligence That Compounds

Every engagement builds on the last. Institutional memory carries forward. Sprint 3 is faster, deeper, and more contextualized than Sprint 1.

Evidence, Not Consensus

Sources weighted, conflicts surfaced, uncertainty named. When the evidence disagrees, you see the disagreement — not an averaged-out answer.

Built to Challenge

Every recommendation survives structured dissent before it reaches you. If the logic has a hole, we find it first.

How It Works

  1. Diagnostic Conversation

    We define the real question, constraints, and what "decision-ready" looks like for your team. Free, no obligation.

  2. Scoped Engagement

    The Brief or The Analysis, depending on complexity. Fixed price, fixed timeline, no surprises.

  3. Delivery

    Evidence-weighted memo or full strategic roadmap. Built to present to leadership, not sit in a drawer.

  4. Ongoing

    The Advisory: quarterly reviews, compounding intelligence, priority access. Most clients start with a sprint and graduate here.

Engagement Tiers

The Brief

Starting at $15,000

One bounded question, decision-ready memo with evidence-weighted confidence scoring and clear recommendation.

Best for: Go/no-go decisions, competitive exposure assessments, market entry gut-checks

~2 week timeline

  • "What's our competitive exposure if Amazon Pharmacy expands into specialty?"
  • "Is there a viable acquisition target in [adjacent market] under $50M?"
  • "What's the real margin risk if [payer] changes reimbursement terms?"

The Analysis

Starting at $25,000

Complex question, full landscape analysis, strategy + implementation roadmap. Everything in The Brief plus: competitive landscape mapping, scenario modeling, implementation sequencing, and strategic debrief.

Best for: Decisions that change how you operate — market entry, business model shifts, competitive repositioning

  • "Should we re-enter DME — and if so, through what model and in what sequence?"
  • "How should we position against vertical integration from [competitor] over the next 18 months?"
  • "What's the build-vs-buy-vs-partner calculus for launching [new service line]?"

The Advisory

Starting at $5,000/month

Ongoing intelligence relationship with compounding decision memory. Quarterly intelligence reviews, persistent decision memory, priority access, and quick-turn intelligence requests.

Best for: Teams facing recurring strategic questions who want each answer to build on the last

Full sprint engagements scoped separately. Advisory clients get priority scheduling and compounding intelligence.

  • "Map our competitive position across pharmacy services and flag shifts quarterly."
  • "Track regulatory signals in [therapeutic area] and brief us monthly on what's changed."

The Brief answers a question. The Analysis answers a question and tells you what to do about it. The Advisory makes sure you're always asking the right questions.

The best time to answer a hard question is before your competitor does.

Tell us what you're trying to figure out.

Start a Conversation